Tumor Suppressor Proteins

"Tumor Suppressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.

Descriptor ID	D025521
MeSH Number(s)	D12.776.624.776
Concept/Terms	Tumor Suppressor Proteins Tumor Suppressor Proteins Proteins, Tumor Suppressor Metastasis Suppressor Proteins Metastasis Suppressor Proteins Proteins, Metastasis Suppressor Growth Suppressor Proteins Growth Suppressor Proteins Proteins, Growth Suppressor

Below are MeSH descriptors whose meaning is more general than "Tumor Suppressor Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Neoplasm Proteins [D12.776.624]
Tumor Suppressor Proteins [D12.776.624.776]

Below are MeSH descriptors whose meaning is related to "Tumor Suppressor Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tumor Suppressor Proteins" by people in this website by year, and whether "Tumor Suppressor Proteins" was a major or minor topic of these publications.

Bar chart showing 151 publications over 28 distinct years, with a maximum of 11 publications in 2010 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	0	1	1
1997	2	0	2
1998	1	0	1
1999	1	1	2
2000	1	3	4
2001	2	1	3
2002	7	3	10
2003	5	4	9
2004	2	6	8
2005	2	3	5
2006	4	4	8
2007	4	1	5
2008	5	4	9
2009	3	3	6
2010	5	6	11
2011	8	3	11
2012	3	3	6
2013	2	4	6
2014	4	4	8
2015	4	3	7
2016	4	3	7
2017	0	1	1
2018	4	2	6
2019	3	2	5
2020	0	2	2
2021	2	4	6
2023	0	1	1

Below are the most recent publications written about "Tumor Suppressor Proteins" by people in Profiles.

Medeiros MC, The S, Bellile E, Russo N, Schmitd L, Danella E, Singh P, Banerjee R, Bassis C, Murphy GR, Sartor MA, Lombaert I, Schmidt TM, Eisbruch A, Murdoch-Kinch CA, Rozek L, Wolf GT, Li G, Chen GY, D'Silva NJ. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome. 2023 Nov 30; 11(1):268.

View in: PubMed
Liu S, Bellile E, Nguyen A, Zarins K, D'Silva N, Rozek L, Wolf GT, Sartor MA. Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen. Oral Oncol. 2021 12; 123:105587.

View in: PubMed
Lv B, Stuck MW, Desai PB, Cabrera OA, Pazour GJ. E3 ubiquitin ligase Wwp1 regulates ciliary dynamics of the Hedgehog receptor Smoothened. J Cell Biol. 2021 09 06; 220(9).

View in: PubMed
Carter P, Schnell U, Chaney C, Tong B, Pan X, Ye J, Mernaugh G, Cotton JL, Margulis V, Mao J, Zent R, Evers BM, Kapur P, Carroll TJ. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021 06 01; 131(11).

View in: PubMed
Huang WY, Wen LH, Wu G, Pang PP, Ogbuji R, Zhang CC, Chen F, Zhao JN. Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis. Cancer Sci. 2021 Jul; 112(7):2835-2844.

View in: PubMed
Politi LS, Pessina F, Simonelli M, Navarria P. Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging". J Magn Reson Imaging. 2021 07; 54(1):237-238.

View in: PubMed
Maor-Nof M, Shipony Z, Lopez-Gonzalez R, Nakayama L, Zhang YJ, Couthouis J, Blum JA, Castruita PA, Linares GR, Ruan K, Ramaswami G, Simon DJ, Nof A, Santana M, Han K, Sinnott-Armstrong N, Bassik MC, Geschwind DH, Tessier-Lavigne M, Attardi LD, Lloyd TE, Ichida JK, Gao FB, Greenleaf WJ, Yokoyama JS, Petrucelli L, Gitler AD. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell. 2021 02 04; 184(3):689-708.e20.

View in: PubMed
Das A, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, Lindhorst SM, Varma AK, Patel SJ, Cachia D. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. J Neurol Sci. 2020 Nov 15; 418:117102.

View in: PubMed
Farina NH, Scalia S, Adams CE, Hong D, Fritz AJ, Messier TL, Balatti V, Veneziano D, Lian JB, Croce CM, Stein GS, Stein JL. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer. J Cell Physiol. 2020 06; 235(6):5318-5327.

View in: PubMed
Shen K, Rogala KB, Chou HT, Huang RK, Yu Z, Sabatini DM. Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex. Cell. 2019 11 27; 179(6):1319-1329.e8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals